Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery

Positron emission tomography (PET) radioligands (radioactively labelled tracer compounds) are extremely useful for in vivo characterization of central nervous system drug candidates, neurodegenerative diseases and numerous oncology targets(1). Both tritium and carbon-11 radioisotopologues are generally necessary for in vitro and in vivo characterization of radioligands(2), yet there exist few radiolabelling protocols for the synthesis of either, inhibiting the development of PET radioligands. The synthesis of such radioligands also needs to be very rapid owing to the short half-life of carbon-11. Here we report a versatile and rapid metallaphotoredox-catalysed method for late-stage installation of both tritium and carbon-11 into the desired compounds via methylation of pharmaceutical precursors bearing aryl and alkyl bromides. Methyl groups are among the most prevalent structural elements found in bioactive molecules, and so this synthetic approach simplifies the discovery of radioligands. To demonstrate the breadth of applicability of this technique, we perform rapid synthesis of 20 tritiated and 10 carbon-11-labelled complex pharmaceuticals and PET radioligands, including a one-step radiosynthesis of the clinically used compounds [C-11]UCB-J and [C-11]PHNO. We further outline the direct utility of this protocol for preclinical PET imaging and its translation to automated radiosynthesis for routine radiotracer production in human clinical imaging. We also demonstrate this protocol for the installation of other diverse and pharmaceutically useful isotopes, including carbon-14, carbon-13 and deuterium.

Automated summary

By utilizing a versatile and rapid metallaphotoredox-catalysed method, both tritium and carbon-11 can be efficiently introduced into pharmaceutical precursors bearing aryl and alkyl bromides, simplifying the synthesis of radioligands and expanding their applicability. This technique has direct utility for preclinical PET imaging and translation to automated radiosynthesis, demonstrating its potential for routine radiotracer production in human clinical imaging.